Entero Healthcare Solutions Limited

About

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label products under the Entero Surgicals private label, such as monitoring devices, nursing and rehabilitation products, and consumables; commercial solutions; and healthcare product distribution solutions, including imports, central warehousing, redistribution, last mile delivery, and connection with the pharmacies, hospitals, and clinics. The company was incorporated in 2018 and is based in Mumbai, India.

Key Metrics

as of Sep 2026

Market Cap7,954 Cr

P/E61.60

Div Yield0.00 %

Book Value₹388.00

52w High₹1,870.00

52w Low₹944.00

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	83.27	78.93	106.74	83.22	79.35	72.30	101.15	112.83	122.38	106.56	76.59	73.81	61.20
Expenses	92.97	101.47	120.62	95.81	93.06	84.23	111.63	118.90	124.23	115.75	85.09	83.00	68.82
Operating Profit	-9.70	-22.54	-13.88	-12.59	-13.71	-11.93	-10.48	-6.07	-1.85	-9.19	-8.50	-9.19	-7.62
OPM %	-11.65	-28.56	-13.00	-15.13	-17.28	-16.50	-10.36	-5.38	-1.51	-8.62	-11.10	-12.45	-12.45
Other Income	23.15	39.96	18.75	24.23	26.29	-21.21	27.51	28.81	32.17	42.40	16.25	16.52	14.76
Depreciation	3.11	2.78	2.80	3.32	2.82	2.16	2.19	2.13	2.17	1.73	2.32	2.29	2.41
Interest	5.74	2.60	0.70	0.71	0.59	0.35	0.37	0.39	0.41	5.61	4.73	7.32	4.65
Profit before tax	4.60	12.04	1.37	7.61	9.17	-35.65	14.47	20.22	27.74	25.87	0.70	-2.28	0.08
Tax %	25.00	-11.38	41.61	25.10	24.10	-22.02	25.50	24.18	24.77	-44.11	-35.71	-6.14	-2,837.50
Net Profit	3.46	13.42	0.81	5.70	6.96	-27.81	10.78	15.33	20.88	37.28	0.95	-2.14	2.36
EPS in Rs	0.79	3.08	0.19	1.31	1.60	-6.39	2.48	3.52	4.80	8.57	0.59	-1.33	5.74

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Sales	348.00	409.00	318.00	178.00	137.00	105.00	56.00
Expenses	411.00	439.00	353.00	222.00	191.00	137.00	73.00
Operating Profit	-63.00	-30.00	-34.00	-44.00	-54.00	-32.00	-17.00
OPM %	-18.00	-7.00	-11.00	-25.00	-39.00	-30.00	-30.00
Other Income	109.00	67.00	90.00	53.00	27.00	23.00	21.00
Interest	5.00	2.00	22.00	11.00	5.00	2.00	1.00
Depreciation	12.00	9.00	9.00	10.00	9.00	7.00	4.00
Profit before tax	30.00	27.00	24.00	-12.00	-41.00	-18.00	-2.00
Tax %	11.00	28.00	-58.00	0.00	0.00	0.00	0.00
Net Profit	27.00	19.00	38.00	-12.00	-41.00	-18.00	-2.00
EPS in Rs	6.18	4.41	8.84	-30.31	-106.10	-1,811.38	-162.67
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Equity Capital	44.00	44.00	43.00	4.00	4.00	0.10	0.10
Reserves	1,640.00	1,607.00	1,583.00	-84.00	-72.00	-31.00	-13.00
Borrowings	133.00	14.00	18.00	775.00	674.00	540.00	457.00
Other Liabilities	342.00	139.00	125.00	68.00	47.00	23.00	21.00
Total Liabilities	2,158.00	1,804.00	1,769.00	764.00	654.00	533.00	466.00
Fixed Assets	47.00	28.00	34.00	41.00	51.00	50.00	46.00
CWIP	2.00	0.00	0.00	0.00	0.00	2.00	2.00
Investments	825.00	277.00	41.00	41.00	39.00	39.00	38.00
Other Assets	1,283.00	1,498.00	1,694.00	682.00	563.00	442.00	380.00
Total Assets	2,158.00	1,804.00	1,769.00	764.00	654.00	533.00	466.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash from Operating Activity	-60.00	-109.00	-76.00	-57.00	-45.00	-68.00	-52.00
Cash from Investing Activity	-132.00	208.00	-763.00	-58.00	-69.00	-7.00	-167.00
Cash from Financing Activity	98.00	-41.00	926.00	91.00	127.00	76.00	178.00
Net Cash Flow	-94.00	58.00	87.00	-24.00	14.00	0.00	-41.00
Free Cash Flow	-75.00	-111.00	-77.00	-57.00	-47.00	-75.00	-75.00
CFO/OP %	89.00	305.00	214.00	124.00	81.00	215.00	293.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Debtor Days	108.00	89.00	130.00	153.00	139.00	107.00	114.00
Inventory Days	85.00	110.00	65.00	68.00	103.00	177.00	206.00
Days Payable	87.00	87.00	88.00	132.00	99.00	48.00	101.00
Cash Conversion Cycle	107.00	112.00	107.00	89.00	143.00	236.00	219.00
Working Capital Days	303.00	432.00	850.00	947.00	1,034.00	1,201.00	2,013.00
ROCE %	2.00	5.00	4.00	0.00	-6.00	-3.00	—

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Promoters	52.40	52.42	52.42	52.42	52.42	52.42	52.44	52.44	52.44	52.44
FIIs	4.36	4.03	5.14	14.68	17.21	19.92	22.20	23.82	23.32	23.30
DIIs	15.48	16.62	16.42	9.64	10.19	9.63	8.78	7.73	2.06	2.28
Public	27.77	26.94	26.03	23.26	20.19	18.03	16.59	16.02	22.18	21.99
No. of Shareholders	39,709	39,084	40,333	36,334	33,338	33,159	33,172	36,767	66,400	80,864